Product MSDS Sheets
| NDC | PRODUCT NAME | MSDS SHEET | ||
| 17478-542-02 | Adenosine Injection, USP 2 mL 3 mg/mL Vial |  | ||
| 17478-542-25 | Adenosine Injection, USP 2 mL 3 mg/mL Vial | | ||
| 17478-253-10 | AK-Fluor® (fluorescein injection, USP) 5 mL 10% Single-dose Vial | | ||
| 17478-250-20 | AK-Fluor® (fluorescein injection, USP) 2 mL 25% Single-dose Vial | | ||
| 17478-238-35 | AK-Poly-Bac™ (bacitracin zinc and polymyxin B sulfate ophthalmic ointment, USP) 3.5 g Sterile Antimicrobial Ointment for Ophthalmic Use | | ||
| 17478-792-01 | Akten® (lidocaine hydrochloride ophthalmic gel) 1 mL 3.5% Sterile Ophthalmic Gel in a Unit-dose Tube | | ||
| 17478-060-12 | Akwa Tears® (artificial tears) 15 mL 1.4% Ocular Lubricant Sterile Ophthalmic Solution | | ||
| 17478-062-35 | Akwa Tears® (artificial tears) 3.5 g Lanolin 2%, Mineral Oil 15% and White Petrolatum 83% Sterile Ophthalmic Ointment | | ||
| 17478-716-10 | Apraclonidine Ophthalmic Solution, USP 5 mL 0.5% as Base Sterile Ophthalmic Solution | | ||
| 17478-716-11 | Apraclonidine Ophthalmic Solution, USP 10 mL 0.5% as Base Sterile Ophthalmic Solution | | ||
| 17478-060-12 | Artificial Tears Solution (polyvinyl alcohol ophthalmic solution) 15 mL 1.4% Ocular Lubricant Sterile Ophthalmic Solution | | ||
| 17478-214-20 | Atropine Care™ (atropine sulfate ophthalmic solution) 2 mL 1% Sterile Ophthalmic Solution | | ||
| 17478-214-10 | Atropine Care™ (atropine sulfate ophthalmic solution) 5 mL 1% Sterile Ophthalmic Solution | | ||
| 17478-214-12 | Atropine Care™ (atropine sulfate ophthalmic solution) 15 mL 1% Sterile Ophthalmic Solution | | ||
| 17478-214-20 | Atropine Sulfate Ophthalmic Solution 2 mL 1% Sterile Ophthalmic Solution | | ||
| 17478-214-10 | Atropine Sulfate Ophthalmic Solution 5 mL 1% Sterile Ophthalmic Solution | | ||
| 17478-214-12 | Atropine Sulfate Ophthalmic Solution 15 mL 1% Sterile Ophthalmic Solution | | ||
| 17478-238-35 | Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment, USP 3.5 g 500 Bacitracin Units and Polymyxin B Sulfate Equal to 10,000 Polymyxin B Units Sterile Antimicrobial Ophthalmic Ointment | | ||
| 17478-920-19 | Balanced Salt Solution 18 mL Sterile Physiological Solution, containing Calcium Chloride 0.48 mg, Magnesium Chloride 0.30 mg, Potassium Chloride 0.75 mg, Sodium Acetate 3.90 mg, Sodium Chloride 6.40 mg, Sodium Citrate 1.70 mg | | ||
| 17478-715-10 | Brimonidine Tartrate Ophthalmic Solution 5 mL 0.2% Sterile Ophthalmic Solution | | ||
| 17478-715-11 | Brimonidine Tartrate Ophthalmic Solution 10 mL 0.2% Sterile Ophthalmic Solution | | ||
| 17478-715-12 | Brimonidine Tartrate Ophthalmic Solution 15 mL 0.2% Sterile Ophthalmic Solution | | ||
| 17478-931-01 | Calcitriol lnjection 1 mL 1 mcg/mL Single-dose Ampule | | ||
| 17478-080-50 | Capastat® Sulfate (capreomycin for injection, USP) 10 mL 1 g Lyophilized Vial | | ||
| 17478-714-10 | Ciprofloxacin Ophthalmic Solution, USP 5 mL 0.3% as Base Sterile Ophthalmic Solution | | ||
| 17478-120-50 | Clindamycin in 5% Dextrose Injection 50 mL 6 mg/mL, 300 mg/50 mL Single-dose Bottle | | ||
| 17478-121-50 | Clindamycin in 5% Dextrose Injection 50 mL 12 mg/mL, 600 mg/50 mL Single-dose Bottle | | ||
| 17478-122-50 | Clindamycin in 5% Dextrose Injection 50 mL 18 mg/mL, 900 mg/50 mL Single-dose Bottle | | ||
| 76478-611-02 | Cogentin® (benztropine mesylate injection) 2 mL 1 mg/mL Ampule | | ||
| 17478-291-11 | Cromolyn Sodium Ophthalmic Solution, USP 10 mL 4% Sterile Ophthalmic Solution | | ||
| 17478-100-02 | Cyclopentolate Hydrochloride Ophthalmic Solution, USP 2 mL 1% Sterile Ophthalmic Solution | | ||
| 17478-100-12 | Cyclopentolate Hydrochloride Ophthalmic Solution, USP 15 mL 1% Sterile Ophthalmic Solution | | ||
| 17478-097-02 | Cyclopentolate Hydrochloride Ophthalmic Solution, USP 2 mL 2% Sterile Ophthalmic Solution | | ||
| 17478-097-10 | Cyclopentolate Hydrochloride Ophthalmic Solution, USP 5 mL 2% Sterile Ophthalmic Solution | | ||
| 17478-097-12 | Cyclopentolate Hydrochloride Ophthalmic Solution, USP 15 mL 2% Sterile Ophthalmic Solution | | ||
| 17478-503-05 | Dehydrated Alcohol Injection, USP 5 mL Not Less Than 98% by Volume of Ethanol (Ethyl Alcohol) Single-dose Vial | | ||
| 17478-892-25 | Diclofenac Sodium Ophthalmic Solution 2.5 mL 0.1% Sterile Ophthalmic Solution | | ||
| 17478-892-10 | Diclofenac Sodium Ophthalmic Solution 5 mL 0.1% Sterile Ophthalmic Solution | | ||
| 17478-937-05 | Diltiazem Hydrochloride Injection 5 mL 5 mg/mL Single-dose Vial | | ||
| 17478-937-10 | Diltiazem Hydrochloride Injection 10 mL 5 mg/mL Single-dose Vial | | ||
| 17478-937-25 | Diltiazem Hydrochloride Injection 25 mL 5 mg/mL Single-dose Vial | | ||
| 63323-289-55 | EMLA® Cream (lidocaine 2.5% and prilocaine 2.5%) 5 g 2.5% Lidocaine and 2.5% Prilocaine | | ||
| 76478-289-30 | EMLA® Cream (lidocaine 2.5% and prilocaine 2.5%) 30 g 2.5% Lidocaine and 2.5% Prilocaine | | ||
| 17478-515-00 | Ephedrine Sulfate Injection, USP 1 mL 50 mg/mL Single-dose Ampule | | ||
| 17478-070-35 | Erythromycin Ophthalmic Ointment, USP 3.5 g 0.5% Sterile Ophthalmic Ointment | | ||
| 17478-070-31 | Erythromycin Ophthalmic Ointment, USP 1 g 0.5% Sterile Ophthalmic Ointment | | ||
| 17478-640-10 | Fluress® (fluorescein sodium and benoxinate hydrochloride ophthalmic solution, USP) 5 mL Fluorescein Sodium 0.25% and Benoxinate HCl 0.4% Sterile Ophthalmic Solution, with Separate Sterile Dropper | | ||
| 17478-284-35 | Gentak® (gentamicin sulfate ophthalmic ointment, USP) 3.5 g 0.3% Sterile Ophthalmic Ointment | | ||
| 17478-283-10 | Gentak® (gentamicin sulfate ophthlamic solution, USP) 5 mL 0.3% Sterile Ophthalmic Solution | | ||
| 17478-283-10 | Gentamicin Sulfate Ophthlamic Solution, USP 5 mL 0.3% Sterile Ophthalmic Solution | | ||
| 17478-064-12 | Gonak™ (hypromellose ophthalmic demulcent solution) 15 mL 2.5% Sterile Hypromellose Ophthalmic Demulcent Solution | | ||
| 17478-546-02 | Granisetron Hydrochloride Injection, USP 1 mL 1 mg/mL Single-use Vial | | ||
| 17478-546-05 | Granisetron Hydrochloride Injection, USP 4 mL 1 mg/mL Multi-use Vial | | ||
| 17478-934-01 | HydrALAZINE Hydrochloride Injection, USP 1 mL 20 mg/mL Single-dose Vial | | ||
| 17478-934-15 | HydrALAZINE Hydrochloride Injection, USP 1 mL 20 mg/mL Single-dose Vial | | ||
| 17478-540-01 | Hydromorphone Hydrochloride, USP CII (High Potency Formulation) 1 mL 10 mg/mL Single-dose Amber Ampule CII | | ||
| 17478-540-05 | Hydromorphone Hydrochloride, USP CII (High Potency Formulation) 5 mL 10 mg/mL Single-dose Amber Ampule CII | | ||
| 17478-540-50 | Hydromorphone Hydrochloride, USP CII (High Potency Formulation) 50 mL 10 mg/mL Single-dose Vial CII | | ||
| 17478-701-02 | IC-Green™ (indocyanine green for injection, USP) 25 mg Vial and 10 mL Ampule (Solvent) 25 mg Sterile Indocyanine Green Single-dose Vials and Sterile Aqueous Solvent Ampules | | ||
| 17478-508-01 | Indigo Carmine™ (indigotindisulfonate sodium injection, USP) 5 mL 8 mg/mL Single-dose Ampule | | ||
| 17478-208-10 | Ketorolac Tromethamine Ophthalmic Solution, 0.4% 5 mL 0.4% Sterile Ophthalmic Solution | | ||
| 17478-209-19 | Ketorolac Tromethamine Ophthalmic Solution, 0.5% 3 mL 0.5% Sterile Ophthalmic Solution | | ||
| 17478-209-10 | Ketorolac Tromethamine Ophthalmic Solution, 0.5% 5 mL 0.5% Sterile Ophthalmic Solution | | ||
| 17478-209-11 | Ketorolac Tromethamine Ophthalmic Solution, 0.5% 10 mL 0.5% Sterile Ophthalmic Solution | | ||
| 17478-717-10 | Ketotifen Fumarate Ophthalmic Solution 5 mL 0.025% Sterile Ophthalmic Solution | | ||
| 17478-420-20 | Labetalol Hydrochloride Injection, USP 20 mL 5 mg/mL Multi-dose Vial, Sterile | | ||
| 17478-420-40 | Labetalol Hydrochloride Injection, USP 40 mL 5 mg/mL Multi-dose Vial, Sterile | | ||
| 17478-107-20 | Levofloxacin Injection, for Intravenous Use 20 mL 25 mg/mL, Single-dose Vial (equivalent to 500 mg of levofloxacin) | | ||
| 17478-107-30 | Levofloxacin Injection, for Intravenous Use 30 mL 25 mg/mL, Single-dose Vial (equivalent to 750 mg of levofloxacin) | | ||
| 17478-106-10 | Levofloxacin Ophthalmic Solution 5 mL 0.5% Sterile Ophthalmic Solution | | ||
| 17478-190-55 | Lidocaine 2.5% and Prilocaine 2.5% Cream, USP 5 g Lidocaine 2.5% and Prilocaine 2.5% | | ||
| 17478-190-30 | Lidocaine 2.5% and Prilocaine 2.5% Cream, USP 30 g Lidocaine 2.5% and Prilocaine 2.5% | | ||
| 17478-711-10 | Lidocaine Hydrochloride Jelly, USP 5 mL 2% Sterile Jelly | | ||
| 17478-711-30 | Lidocaine Hydrochloride Jelly, USP 30 mL 2% Sterile Jelly | | ||
| 17478-501-01 | Methylergonovine Maleate Injection, USP 1 mL 0.2 mg/mL Ampule | | ||
| 17478-061-12 | Natural Tears Solution (hypromellose and dextran solution) 15 mL 0.3% Hypromellose, 0.1% Dextran 70 Sterile Lubricant Ophthalmic Solution | | ||
| 76478-501-20 | Nembutal® Sodium Solution CII (pentobarbital sodium injection, USP) 20 mL 50 mg/mL Multi-dose Vial | | ||
| 76478-501-50 | Nembutal® Sodium Solution CII (pentobarbital sodium injection, USP) 50 mL 50 mg/mL Multi-dose Vial | | ||
| 17478-235-35 | Neomycin and Polymyxin B Sulfates and Bacitracin Zinc Ophthalmic Ointment, USP 3.5 g Neomycin Sulfate (equivalent to 3.5 mg Neomycin base), Polymyxin B Sulfate equal to 10,000 Polymyxin B units, Bacitracin Zinc equal to 400 Bacitracin units and White Petrolatum, q.s. Sterile Ophthalmic Ointment | | ||
| 17478-719-35 | Neomycin and Polymyxin B Sulfates, Bacitracin Zinc, and Hydrocortisone Ophthalmic Ointment, USP 3.5 g Neomycin Sulfate (equivalent to 3.5 mg neomycin base), Polymyxin B Sulfate equal to 10,000 polymyxin B units, Bacitracin Zinc equivalent to 400 bacitracin units, Hydrocortisone 10 mg (1%); and White Petrolatum q.s. Sterile Ophthalmic Ointment | | ||
| 17478-713-10 | Ofloxacin Ophthalmic Solution, USP 5 mL 0.3% Sterile Ophthalmic Solution | | ||
| 17478-713-11 | Ofloxacin Ophthalmic Solution, USP 10 mL 0.3% Sterile Ophthalmic Solution | | ||
| 17478-538-02 | Orphenadrine Citrate Injection, USP 2 mL 30 mg/mL Single-dose Vial | | ||
| 17478-069-14 | Pantoprazole Sodium for Injection N/A 40 mg Lyophilized Single-dose Vial | | ||
| 17478-704-12 | Paremyd® (hydroxyamphetamine hydrobromide and tropicamide ophthalmic solution) 15 mL Hydroxyamphetamine Hydrobromide 1% and Tropicamide 0.25% Ophthalmic Solution | | ||
| 17478-151-42 | Rifampin for Injection, USP N/A 600 mg Lyophilized Vial | | ||
| 17478-622-35 | Sodium Chloride Ophthalmic Ointment, USP 3.5 g 5% Hypertonicity Sterile Ophthalmic Ointment | | ||
| 17478-623-12 | Sodium Chloride Ophthalmic Solution, USP 15 mL 5% Hypertonicity Eye Drops | | ||
| 76478-711-40 | Sodium Diuril® (chlorothiazide sodium) N/A 0.5 g Lyophilized White Powder Vial | | ||
| 17478-050-01 | Sufenta® CII (sufentanil citrate injection) 1 mL 50 mcg/mL Ampule CII | | ||
| 17478-050-02 | Sufenta® CII (sufentanil citrate injection) 2 mL 50 mcg/mL Ampule CII | | ||
| 17478-050-05 | Sufenta® CII (sufentanil citrate injection) 5 mL 50 mcg/mL Ampule CII | | ||
| 17478-061-12 | Tears Renewed® (artificial tear solution) 15 mL 0.3% Hypromellose, 0.1% Dextran 70 Sterile Lubricant Ophthalmic Solution | | ||
| 17478-703-11 | Trimethoprim Sulfate and Polymyxin B Sulfate Ophthalmic Solution 10 mL Trimethoprim Sulfate 0.1%, Polymyxin B Sulfate 10,000 units Sterile Ophthalmic Solution | | ||
| 17478-101-12 | Tropicacyl® (tropicamide sterile ophthalmic solution, USP) 15 mL 0.5% Sterile Ophthalmic Solution | | ||
| 17478-102-12 | Tropicacyl® (tropicamide sterile ophthalmic solution, USP) 15 mL 1% Sterile Ophthalmic Solution | | ||
| 17478-101-12 | Tropicamide Sterile Ophthalmic Solution, USP 15 mL 0.5% Sterile Ophthalmic Solution | | ||
| 17478-102-12 | Tropicamide Sterile Ophthalmic Solution, USP 15 mL 1% Sterile Ophthalmic Solution | | ||
| 63323-479-30 | Xylocaine® (lidocaine hydrochloride) 30 mL 2% Sterile Jelly | |
Don't have Adobe Acrobat or Adobe Reader? DOWNLOAD HERE